BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11361749)

  • 1. The changing mycology of candidiasis: new and resistant pathogens.
    Rinaldi MG
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S5-8; discussion S9. PubMed ID: 11361749
    [No Abstract]   [Full Text] [Related]  

  • 2. [The identification of freshly isolated strains, the causative agents of human candidiasis and the search for effective antifungal probiotics].
    Polishchuk OI; Koltukova NV; Cherniavs'ka LM; Reva OM; Sorokulova IB
    Mikrobiol Z; 1999; 61(4):45-53. PubMed ID: 10565150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis and treatment of candidiasis: current therapeutic options.
    Filler SG
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S10-4; discussion S15. PubMed ID: 11361745
    [No Abstract]   [Full Text] [Related]  

  • 4. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.
    Baily GG; Moore CB; Essayag SM; de Wit S; Burnie JP; Denning DW
    Clin Infect Dis; 1997 Jul; 25(1):161-3. PubMed ID: 9243058
    [No Abstract]   [Full Text] [Related]  

  • 5. Candida pelliculosa meningitis as an opportunistic infection in HIV: the first reported case.
    Ratcliffe L; Davies J; Anson J; Hales S; Beeching NJ; Beadsworth MB
    Int J STD AIDS; 2011 Jan; 22(1):54-6. PubMed ID: 21364070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal and esophageal candidiasis in HIV disease: emerging pathogens, changing therapies.
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S1-25; quiz S26-7. PubMed ID: 11361744
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of Candida species other than Candida albicans as opportunistic pathogens.
    Coleman DC; Rinaldi MG; Haynes KA; Rex JH; Summerbell RC; Anaissie EJ; Li A; Sullivan DJ
    Med Mycol; 1998; 36 Suppl 1():156-65. PubMed ID: 9988504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The problems of Candida infection in the HIV-positive patient].
    Arrizabalaga Aguirreazaldegui J; Rodríguez Arrondo F; Iribarren Loyarte JA; von Wichmann de Miguel MA
    Rev Clin Esp; 1997 Apr; 197 Suppl 1():44-8. PubMed ID: 9297206
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida fermentati from HIV patients in Chennai, South India.
    Umamaheswari K; Menon T
    Int J Infect Dis; 2008 Nov; 12(6):e153-4. PubMed ID: 18650108
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
    Laverdière M; Lalonde RG; Baril JG; Sheppard DC; Park S; Perlin DS
    J Antimicrob Chemother; 2006 Apr; 57(4):705-8. PubMed ID: 16464893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical case presentations. Oropharyngeal and esophageal candidiasis in HIV disease.
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S22-5. PubMed ID: 11361748
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral candidiasis in pediatric HIV patients.
    Lal S; Chussid S
    N Y State Dent J; 2005 Mar; 71(2):28-31. PubMed ID: 15887466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics.
    Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP
    Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oesophageal candidiasis: clinical and mycological analysis].
    Olmos MA; Araya V; Concetti H; Ramallo J; Piskorz E; Pérez H; Cahn P; Kaufman S; Guelfand L
    Acta Gastroenterol Latinoam; 2005; 35(4):211-8. PubMed ID: 16496852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing therapy for Candida infections.
    Playford EG; Sorrell TC
    Semin Respir Crit Care Med; 2007 Dec; 28(6):678-88. PubMed ID: 18095232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida infection in HIV positive patients 1985-2007.
    Traeder C; Kowoll S; Arastéh K
    Mycoses; 2008 Sep; 51 Suppl 2():58-61. PubMed ID: 18721333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.